PCV-13: 13-valent pneumococcal conjugate vaccine; PHiD-CV: 10-valent pneumococcal nontypable Haemophilus influenzae protein D-conjugate vaccine. Table modified from [13] with additional data from ...
and 13-valent pneumococcal conjugate vaccine (PCV13) account for pneumococcal disease burdens in most developed countries of 65–85% and 80–90%, respectively. The seroprevalence of NVTs after ...